Search results
Bristol Myers to pay $2.7 million to settle Israel anti-competition charges
Reuters via Yahoo Singapore Finance· 1 week agoBristol Myers Squibb has agreed to pay 10 million shekels ($2.7 million) in Israel to settle a...
Investors Heavily Search Bristol Myers Squibb Company (BMY): Here is What You Need to Know
Zacks via Yahoo Singapore Finance· 2 weeks agoBristol Myers (BMY) has received quite a bit of attention from Zacks.com users lately. Therefore, it...
Bristol Myers Squibb (BMY) Stock Declines While Market Improves: Some Information for Investors
Zacks via Yahoo Singapore Finance· 2 weeks agoBristol Myers Squibb (BMY) ended the recent trading session at $42.19, demonstrating a -0.09% swing...
FDA Approves Bristol Myers Squibb's Combination Therapy For Colorectal Cancer Patients With Certain...
Benzinga via Yahoo Singapore Finance· 2 weeks agoFriday, the FDA granted accelerated approval to Bristol Myers Squibb & Co’s (NYSE:BMY) Krazati...
Bristol Myers' (BMY) Krazati Gets FDA Nod for Colorectal Cancer
Zacks via Yahoo Singapore Finance· 2 weeks agoBristol Myers (BMY) wins FDA approval for Krazati, in combination with Erbitux, as a targeted...
FDA Approves Geron's First Commercial Drug, Competes With Bristol Myers Squibb's Blood Cancer Drug
Benzinga via Yahoo Singapore Finance· 1 month agoOn Thursday, the FDA approved Geron Corporation's (NASDAQ:GERN) Rytelo (imetelstat) for adult...
Bristol Myers Squibb (BMY) Stock Sinks As Market Gains: What You Should Know
Zacks via Yahoo Singapore Finance· 3 weeks agoBristol Myers Squibb (BMY) closed the most recent trading day at $40.81, moving -0.39% from the...
Bristol Myers Squibb (BMY) Beats Stock Market Upswing: What Investors Need to Know
Zacks via Yahoo Singapore Finance· 4 weeks agoBristol Myers Squibb (BMY) ended the recent trading session at $43.02, demonstrating a +1.06% swing...
Here’s Why Jim Cramer Says You Should Not Buy Bristol-Myers Squibb Co (NYSE:BMY)
Insider Monkey via Yahoo Singapore Finance· 1 month agoWe recently published the list of 11 stocks Jim Cramer is bearish on. Bristol-Myers Squibb Co...
Shareholders in Bristol-Myers Squibb (NYSE:BMY) are in the red if they invested a year ago
Simply Wall St. via Yahoo Singapore Finance· 1 month agoThe simplest way to benefit from a rising market is to buy an index fund. But if you buy individual...